ArrowMark Colorado Holdings’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-161,970
Closed -$15.8M 314
2015
Q1
$15.8M Sell
161,970
-77,690
-32% -$7.58M 0.41% 79
2014
Q4
$22.2M Buy
239,660
+18,491
+8% +$1.72M 0.57% 59
2014
Q3
$15.2M Buy
221,169
+23,556
+12% +$1.62M 0.42% 79
2014
Q2
$20.7M Buy
197,613
+86,057
+77% +$9.02M 0.59% 62
2014
Q1
$9.26M Sell
111,556
-120,919
-52% -$10M 0.3% 118
2013
Q4
$15M Buy
232,475
+131,125
+129% +$8.49M 0.47% 83
2013
Q3
$6.43M Buy
101,350
+85,850
+554% +$5.44M 0.21% 140
2013
Q2
$651K Buy
+15,500
New +$651K 0.18% 74